Related Experiment Video

Updated: Jun 8, 2026

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
07:46

Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat

Published on: June 4, 2012

Comparison of antimicrobial agents as therapy for experimental endocarditis: caused by methicillin-resistant

Mustafa Sacar1, Suzan Sacar, Nural Cevahir

  • 1Departments of Cardiovascular Surgery, Faculty of Medicine, Pamukkale University, Kinikli, 20070 Denizli, Turkey. mustafasacar@hotmail.com

Texas Heart Institute Journal
|September 17, 2010
PubMed

Insights

This study compared four antibiotics for treating infective endocarditis in rats. All tested antibiotics, including vancomycin, teicoplanin, linezolid, and quinupristin/dalfopristin, effectively reduced bacterial growth in aortic valve vegetations.

Area of Science:

  • Infectious Diseases
  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Infective endocarditis (IE) is a serious infection of the heart's inner lining, often caused by Staphylococcus aureus.
  • Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant challenge in treating IE due to antimicrobial resistance.
  • Vancomycin is a standard therapy, but newer agents are being evaluated for improved efficacy and safety.

Purpose of the Study:

  • To compare the therapeutic efficacy of teicoplanin, linezolid, and quinupristin/dalfopristin against vancomycin in an experimental rat model of infective endocarditis.
  • To evaluate the impact of these antibiotics on bacterial load in aortic valve vegetations.

Main Methods:

  • An experimental rat model of aortic endocarditis was established using catheter insertion and inoculation with methicillin-resistant Staphylococcus aureus.
  • Antibiotic therapies, including vancomycin, teicoplanin, linezolid, and quinupristin/dalfopristin, were administered intravenously 48 hours post-infection.
  • Microbiological evaluation of aortic valve vegetations was performed at the end of the treatment period to quantify bacterial titers.

Main Results:

  • All tested antibiotic regimens significantly reduced bacterial titers in aortic valve vegetations compared to untreated controls.
  • Vancomycin, teicoplanin, and quinupristin/dalfopristin demonstrated comparable efficacy in reducing bacterial cultures.
  • While vancomycin showed a significant reduction compared to linezolid, linezolid was also found to be effective.

Conclusions:

  • The experimental model demonstrated that teicoplanin, linezolid, and quinupristin/dalfopristin are effective alternatives for treating infective endocarditis caused by MRSA.
  • These findings support the potential utility of these agents in clinical settings, offering options beyond vancomycin.
  • Further clinical studies are warranted to confirm these results in human patients.
Keywords:
Anti-bacterial agents/pharmacology/therapeutic useStaphylococcus aureus/drug effectsdisease models, animaldrug resistance, microbialendocarditis, bacterial/microbiology/drug therapylinezolidmethicillin resistancemicrobial sensitivity testsrodentsstaphylococcal infections/epidemiologyteicoplaninvancomycin

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...